Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.
OpenAI CEO Sam Altman said he would grant "employee level" access to outside researchers to evaluate AI safety. The pilot ...
Good morning, everyone, and thank you for joining Recursion's Third Quarter Earnings Call. We're hosting earnings live from the CGA-IGC Annual Meeting in Denver. Today, we'll share the new FAP data ...
A newly developed 5G uplink scheduling algorithm optimizes resource allocation by dynamically balancing throughput, fairness, ...
Recursion has secured FDA alignment on a Phase 3 design for REC-4881, including a novel endpoint focused on clinically meaningful adenoma removal. The step moves the program toward a registrational ...
Management is implementing a disciplined capital allocation strategy, lowering 2026 cash operating expense guidance to $375 million and projecting a further reduction to under $360 million in 2027.
Do you use Git daily? Are you developing frontends with Vite? On November 10, 2026, security updates were released for both ...
A $10 million Sanofi milestone drove revenue 258% higher year over year, beating expectations and showing the AI platform converts into partner cash. October's raise pushed pro forma cash near ...
Revenue increase driven primarily by Sanofi collaboration, including a $10.0 million milestone for an immunology small molecule program R&D expense decreased mainly due to non-recurrence of $22.8 ...